Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Rapid One-Pot Solvothermal Batch Synthesis of Porous Nanocrystal Assemblies Composed of Multiple Transition-Metal Elements.

Ohtani M, Muraoka T, Okimoto Y, Kobiro K.

Inorg Chem. 2017 Sep 15. doi: 10.1021/acs.inorgchem.7b01192. [Epub ahead of print]

PMID:
28915029
2.

Factors affecting oxidative peat decomposition due to land use in tropical peat swamp forests in Indonesia.

Itoh M, Okimoto Y, Hirano T, Kusin K.

Sci Total Environ. 2017 Dec 31;609:906-915. doi: 10.1016/j.scitotenv.2017.07.132. Epub 2017 Aug 7.

PMID:
28783903
3.

Soil carbon dioxide emissions from a rubber plantation on tropical peat.

Wakhid N, Hirano T, Okimoto Y, Nurzakiah S, Nursyamsi D.

Sci Total Environ. 2017 Mar 1;581-582:857-865. doi: 10.1016/j.scitotenv.2017.01.035. Epub 2017 Jan 12.

PMID:
28088548
4.

Direct observation of collective modes coupled to molecular orbital-driven charge transfer.

Ishikawa T, Hayes SA, Keskin S, Corthey G, Hada M, Pichugin K, Marx A, Hirscht J, Shionuma K, Onda K, Okimoto Y, Koshihara SY, Yamamoto T, Cui H, Nomura M, Oshima Y, Abdel-Jawad M, Kato R, Miller RJ.

Science. 2015 Dec 18;350(6267):1501-5. doi: 10.1126/science.aab3480.

PMID:
26680192
5.

Ultrafast electronic state conversion at room temperature utilizing hidden state in cuprate ladder system.

Fukaya R, Okimoto Y, Kunitomo M, Onda K, Ishikawa T, Koshihara S, Hashimoto H, Ishihara S, Isayama A, Yui H, Sasagawa T.

Nat Commun. 2015 Oct 20;6:8519. doi: 10.1038/ncomms9519.

6.

Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma.

Hishiki T, Horie H, Higashimoto Y, Yotsumoto K, Komatsu S, Okimoto Y, Kakuda H, Taneyama Y, Saito T, Terui K, Mitsunaga T, Nakata M, Ochiai H, Hino M, Ando K, Yoshida H, Iwai J.

Pediatr Surg Int. 2014 Sep;30(9):919-26. doi: 10.1007/s00383-014-3564-0. Epub 2014 Jul 27.

PMID:
25064228
7.

Salvage allogeneic stem cell transplantation in patients with pediatric myelodysplastic syndrome and myeloproliferative neoplasms.

Kato M, Yoshida N, Inagaki J, Maeba H, Kudo K, Cho Y, Kurosawa H, Okimoto Y, Tauchi H, Yabe H, Sawada A, Kato K, Atsuta Y, Watanabe K.

Pediatr Blood Cancer. 2014 Oct;61(10):1860-6. doi: 10.1002/pbc.25121. Epub 2014 Jun 29.

PMID:
24976435
8.

No impact of high-dose cytarabine and asparaginase as early intensification with intermediate-risk paediatric acute lymphoblastic leukaemia: results of randomized trial TCCSG study L99-15.

Kato M, Koh K, Manabe A, Saito T, Hasegawa D, Isoyama K, Kinoshita A, Maeda M, Okimoto Y, Kajiwara M, Kaneko T, Sugita K, Kikuchi A, Tsuchida M, Ohara A.

Br J Haematol. 2014 Feb;164(3):376-83. doi: 10.1111/bjh.12632. Epub 2013 Oct 26.

PMID:
24164537
9.

Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.

Ishida Y, Maeda M, Urayama KY, Kiyotani C, Aoki Y, Kato Y, Goto S, Sakaguchi S, Sugita K, Tokuyama M, Nakadate N, Ishii E, Tsuchida M, Ohara A; QOL committee of Tokyo Children's Cancer Study Group (TCCSG).

Br J Haematol. 2014 Jan;164(1):101-12. doi: 10.1111/bjh.12602. Epub 2013 Oct 10.

PMID:
24116892
10.

Optimal surgical treatment and urological outcomes in boys with pelvic and urogenital rhabdomyosarcomas and soft tissue sarcomas.

Hishiki T, Saito T, Mitsunaga T, Nakata M, Terui E, Komatsu S, Mise N, Harada K, Iwai J, Higashimoto Y, Okimoto Y, Kakuda H, Ochiai H, Hino M, Homma S, Osa Y, Yoshida H.

Pediatr Surg Int. 2013 Oct;29(10):1077-82. doi: 10.1007/s00383-013-3400-y.

PMID:
23989524
11.

Expression of CD203c on basophils as a marker of immunoglobulin E-mediated (L)-asparaginase allergy.

Hino M, Shimojo N, Ochiai H, Inoue Y, Ando K, Chikaraishi K, Ota S, Okimoto Y, Sunami S, Nakamura R, Teshima R, Sato Y, Kohno Y.

Leuk Lymphoma. 2014 Jan;55(1):92-6. doi: 10.3109/10428194.2013.794944. Epub 2013 May 15.

PMID:
23581640
12.

Probing the metal-insulator phase transition in the (DMEDO-EBDT)2PF6 single crystal by optical measurements.

Ishikawa T, Kitayama M, Chono A, Onda K, Okimoto Y, Koshihara S, Nakano Y, Yamochi H, Morikawa T, Shirahata T, Misaki Y.

J Phys Condens Matter. 2012 May 16;24(19):195501. doi: 10.1088/0953-8984/24/19/195501. Epub 2012 Apr 13.

PMID:
22498453
13.

The principal results of the International Immune Tolerance Study: a randomized dose comparison.

Hay CR, DiMichele DM; International Immune Tolerance Study.

Blood. 2012 Feb 9;119(6):1335-44. doi: 10.1182/blood-2011-08-369132. Epub 2011 Nov 18.

14.

Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.

Sekimizu M, Sunami S, Nakazawa A, Hayashi Y, Okimoto Y, Saito AM, Horibe K, Tsurusawa M, Mori T.

Br J Haematol. 2011 Sep;154(5):612-7. doi: 10.1111/j.1365-2141.2011.08788.x. Epub 2011 Jun 21.

PMID:
21689091
15.

A case of mediastinal lymphangioma successfully treated with Kampo medicine.

Ogawa-Ochiai K, Sekiya N, Kasahara Y, Chino A, Ueda K, Kimata Y, Yamamoto S, Okimoto Y, Higashimoto H, Namiki T, Terasawa K.

J Altern Complement Med. 2011 Jun;17(6):563-5. doi: 10.1089/acm.2010.0562. Epub 2011 May 13.

PMID:
21568721
16.

The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.

Hasegawa D, Manabe A, Ohara A, Kikuchi A, Koh K, Kiyokawa N, Fukushima T, Ishida Y, Saito T, Hanada R, Tsuchida M; Tokyo Children's Cancer Study Group.

Pediatr Blood Cancer. 2012 Jan;58(1):23-30. doi: 10.1002/pbc.22965. Epub 2011 Jan 19.

PMID:
21254378
17.

Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.

Kudo K, Hama A, Kojima S, Ishii R, Morimoto A, Bessho F, Sunami S, Kobayashi N, Kinoshita A, Okimoto Y, Tawa A, Tsukimoto I.

Int J Hematol. 2010 May;91(4):630-5. doi: 10.1007/s12185-010-0549-1. Epub 2010 Mar 18.

PMID:
20237876
18.

Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.

Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kamijo T.

Oncogene. 2010 May 6;29(18):2681-90. doi: 10.1038/onc.2010.22. Epub 2010 Mar 1.

PMID:
20190806
19.

Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.

Tsuchida M, Ohara A, Manabe A, Kumagai M, Shimada H, Kikuchi A, Mori T, Saito M, Akiyama M, Fukushima T, Koike K, Shiobara M, Ogawa C, Kanazawa T, Noguchi Y, Oota S, Okimoto Y, Yabe H, Kajiwara M, Tomizawa D, Ko K, Sugita K, Kaneko T, Maeda M, Inukai T, Goto H, Takahashi H, Isoyama K, Hayashi Y, Hosoya R, Hanada R; Tokyo Children's Cancer Study Group.

Leukemia. 2010 Feb;24(2):383-96. doi: 10.1038/leu.2009.260. Epub 2009 Dec 24.

PMID:
20033052
20.

Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.

Morimoto A, Ishida Y, Suzuki N, Ohga S, Shioda Y, Okimoto Y, Kudo K, Ishii E; HLH/LCH Committee of the Japanese Society of Pediatric Hematology.

Pediatr Blood Cancer. 2010 Jan;54(1):98-102. doi: 10.1002/pbc.22224.

PMID:
19728332

Supplemental Content

Loading ...
Support Center